Key Efficacy Comparison Year 1 Outcomes: For chronic weight management in adults without diabetes, tirzepatide 15 mg achieved a mean 22.5% total body weight reduction in SURMOUNT-1 (N Engl J Med, 2022), while semaglutide 2.4 mg delivered approximately 15% in the STEP program
Pancreatitis is the inflammation of the pancreas
Successfully maintaining weight loss after discontinuing semaglutide requires a comprehensive, proactive approach that addresses the biological, behavioral, and environmental factors contributing to weight regain
Use this time to practice hitting your protein targets, eating nutrient-dense foods, and establishing a meal schedule that works for your lifestyle
With some lifestyle changes, you can overcome the effects and maintain your new healthy weight